A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the side-effects and effectiveness of a new type of
chemoradiotherapy treatment for patients who have had surgery for stomach cancer. The
treatment uses epirubicin, cisplatin, and 5-fluorouracil (ECF) chemotherapy together with
radiotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group Trans-Tasman Radiation Oncology Group (TROG)
Collaborator:
The Royal Australian and New Zealand College of Radiologists